Recent initial public offerings in the Drugs & Pharmaceuticals IPOs category.
This Slide: #1 of 51 |
Slide #1. Syros Pharmaceuticals — Initial Public Offering
Company:
Syros Pharmaceuticals
Proposed Symbol:
SYRS
Shares Offered:
4,000,000
Price Per Share:
$12.50
Over-Allotment:
600,000
Description:
Syros Pharmaceuticals today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of $12.50 per share, before underwriting discounts and commissions. In addition, Syros has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of common stock from Syros at the public offering price, less the underwriting discount and commissions, to cover over-allotments, if any. All of the shares are being offered by Syros Pharmaceuticals. The Company's shares are scheduled to begin trading on The NASDAQ Global Select Market on June 30, 2016 under the ticker symbol "SYRS." The offering is expected to close on July 6, 2016, subject to customary closing conditions.